6533b832fe1ef96bd129a1e9

RESEARCH PRODUCT

Rapamycin and Zoledronic Acid strongly retard growth of advanced murine hepatocellular carcinoma via skewing and activation of innate and adaptive immunity

Detlef SchuppanM. Ashfaq-khanM. AslamMuhammad Asif Qureshi

subject

Zoledronic acidbusiness.industryHepatocellular carcinomaGastroenterologyCancer researchMedicineRetardbusinessmedicine.diseaseAcquired immune systemmedicine.drughttps://doi.org/10.1055/s-0038-1668946